Lin Zhu

机构：Hebei Medical University, China Three Gorges Corporation (China) · ORCID：0000-0001-5772-9482

发表论文 109 篇 · 总被引 2225 次 · h-index 22

代表论文

• Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma (2025 · Nature Genetics · 被引 96)
• The progress and prospects of targeting the adenosine pathway in cancer immunotherapy (2025 · Biomarker Research · 被引 47)
• A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primates (2024 · Nature Communications · 被引 23)
• Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration (2024 · Nature Communications · 被引 23)
• Animal models of human herpesvirus infection (2025 · Animal Models and Experimental Medicine · 被引 13)
• Integrative spatial multiomics analysis reveals regulatory mechanisms of VCAM1+ proximal tubule cells in lupus nephritis (2025 · Annals of the Rheumatic Diseases · 被引 9)